Effectiveness of COVID-19 Treatment With Nirmatrelvir–Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month Outcomes
Annals of Internal Medicine · 2023
DOI: 10.7326/m22-3565 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Annals of Internal Medicine, 2023. Verfasst von Kristina L Bajema und 18 weiteren Autor:innen. Beteiligte Einrichtung: Veterans Affairs Portland Health Care System, and Division of Infectious Diseases, Department of Medicine, Oregon Health & Science University, Portla…. Hauptthemen laut MEDLINE: COVID-19, Veterans. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HSRD VA, NHLBI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Veterans Affairs Portland Health Care System, and Division of Infectious Diseases, Department of Medicine, Oregon Health & Science University, Portland, Oregon (K.L.B.).
- Research and Development, Veterans Affairs Puget Sound Health Care System, Seattle, Washington (K.B.).
- Veterans Affairs Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut (E.S., Y.L.).
- Veterans Affairs Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, and Yale Center for Medical Informatics, Yale Schoo…
- Veterans Affairs Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, and Department of Biostatistics, Yale School of Pub…
- Veterans Affairs Center for Medication Safety - Pharmacy Benefit Management (PBM) Services, Hines, Illinois (F.C.).
Förderung
- HSRD VA
- NHLBI NIH HHS
Zitieren
APA
Bajema, K. L., Berry, K., Streja, E., Rajeevan, N., Li, Y., Mutalik, P., Yan, L., Cunningham, F., Hynes, D. M., Rowneki, M., Bohnert, A., Boyko, E. J., Iwashyna, T. J., Maciejewski, M. L., Osborne, T. F., Viglianti, E. M., Aslan, M., Huang, G. D., & Ioannou, G. N. (2023). Effectiveness of COVID-19 Treatment With Nirmatrelvir–Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month Outcomes. Annals of Internal Medicine. https://doi.org/10.7326/m22-3565
Vancouver
Bajema KL, Berry K, Streja E, Rajeevan N, Li Y, Mutalik P, et al. Effectiveness of COVID-19 Treatment With Nirmatrelvir–Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month Outcomes. Annals of Internal Medicine. 2023. doi:10.7326/m22-3565
BibTeX
@article{Bajema2023,
author = {Bajema, Kristina L and Berry, Kristin and Streja, Elani and Rajeevan, Nallakkandi and Li, Yuli and Mutalik, Pradeep and Yan, Lei and Cunningham, Francesca and Hynes, Denise M and Rowneki, Mazhgan and Bohnert, Amy and Boyko, Edward J and Iwashyna, Theodore J and Maciejewski, Matthew L and Osborne, Thomas F and Viglianti, Elizabeth M and Aslan, Mihaela and Huang, Grant D and Ioannou, George N},
title = {Effectiveness of COVID-19 Treatment With Nirmatrelvir–Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month Outcomes},
journal = {Annals of Internal Medicine},
year = {2023},
doi = {10.7326/m22-3565}
}
EUVIMED